February 26, 2008 — /PRNewswire/ — BURLINGTON, MA — Hyaluron Contract Manufacturing (HCM), a leading provider of pharmaceutical development services, continued to expand its business in 2007 with revenues increasing greater than 75 percent and staffing increasing greater than 60 percent to support past and anticipated future growth. Additionally, HCM acquired additional space at its Burlington, MA facility to expand its analytical chemistry, microbiology, and engineering laboratories, as well as to provide additional manufacturing capacity.
“We are very proud of our recent growth,” Shawn Kinney, president of HCM states. “It’s a reflection of our ongoing commitment to continuous improvements and to providing high quality products and services to our customers.”
HCM has continued to strengthen its management team with the appointment of Susan McNamara to the newly created position of director of quality, Christopher Paolillo to the position of director of contract administration and legal affairs, and other key hires.
Susan McNamara has over seventeen years of experience in the biotechnology industry, bringing novel recombinant proteins into clinical and commercial production. Before joining HCM, McNamara was associate director, QC microbiology at Wyeth Biotech. Prior to that, McNamara was employed by Fisons Pharmaceuticals and SmithKline.
Christopher Paolillo has over twenty-seven years of experience as corporate counsel and as an attorney in private practice and with the office of Air Force Judge Advocate. He brings to HCM substantial experience in contracts, licensing, intellectual property, and commercial transactions. Prior to HCM, Paolillo was employed by ACI Worldwide (formerly P&H Solutions) as vice president and corporate counsel.
Located in Burlington, MA, HCM has been offering aseptic formulation and filling services to biotechnology and pharmaceutical companies. At the core of HCM’s business is a commitment to quality, regulatory compliance, and on-time delivery.